Looking to publish in Multiple Sclerosis and Related Disorders? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginMultiple Sclerosis and Related Disorders is a comprehensive journal dedicated to advancing the understanding, diagnosis and treatment of multiple sclerosis and related immune-mediated and infectious diseases of the central nervous system. Its scope includes clinical neurology, neuroepidemiology, neurobiology, neuroimaging, neuroimmunology, genetics, biomarkers, neuropsychology, neurorehabilitation, and novel therapeutics, and it welcomes Original Research, Reviews, Clinical Trials, Letters to the Editors, Editorials, and Commentaries.
Looking to publish in Multiple Sclerosis and Related Disorders? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Multiple Sclerosis and Related Disorders accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Clinical Trials
Full Length Research Papers
Letters To The Editors
Recent Publications
Comment on “Lacosamide effects on pain management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial”
Antonio Alcántara Montero, Almudena Holguera Palacios
Examining intersections of biographies & biologies: diversity & outcomes of people with multiple sclerosis in Canada (iBio2Div-MS) Protocol
Ruth Ann Marrie, Kaarina Kowalec, Afolasade Fakolade, John Fisk, Sarah J. Donkers, Colleen J. Maxwell, Penelope Smyth, Christina Wolfson, Marcia Finlayson
Comment on "The utility of magnetic resonance imaging of the spinal cord in paediatric transverse myelitis: A systematic review"
Pierre Meyer
Effects of Blood Flow Restriction Therapy on Lower-Limb Strength in Multiple Sclerosis: A Systematic Review and meta-analysis
Andrea Blanco Trillo, Irimia Mollinedo-Cardalda, Claudia Guerra Colemenero, Diego Fernández-Vázquez
Prevalence and clinical associations of sleep-disordered breathing in multiple sclerosis: a systematic review and meta-analysis
Dwiti Jatin Ponda, Florence Olivia Wong, Laura Edwards
Frequently asked questions
How long does it take to publish?
4 days submission to first decision; 54 days submission to decision after review; 115 days submission to acceptance; 2 days acceptance to online publication.
Reformat to Multiple Sclerosis and Related Disorders using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3450 excluding taxes. Subscription publication has no open access publication fee.
Reformat to Multiple Sclerosis and Related Disorders using Livewrite Premium